|
🐜
|
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
99 auth.
J. Kuhle,
G. Disanto,
R. Dobson,
R. Adiutori,
L. Bianchi,
J. Topping,
J. Bestwick,
U. Meier,
M. Marta,
G. Costa,
T. Runia,
E. Evdoshenko,
N. Lazareva,
E. Thouvenot,
P. Iaffaldano,
...
V. Direnzo,
M. Khademi,
F. Piehl,
M. Comabella,
M. Sombekke,
J. Killestein,
H. Hegen,
S. Rauch,
S. D'alfonso,
J. Álvarez-cermeño,
P. Kleinova,
D. Horáková,
Romy Roesler,
F. Lauda,
S. Llufriu,
Timuçin Avşar,
U. Uygunoğlu,
A. Altıntaş,
S. Saip,
T. Menge,
C. Rajda,
R. Bergamaschi,
N. Moll,
M. Khalil,
R. Marignier,
I. Dujmovic,
Henrik Larsson,
C. Malmeström,
E. Scarpini,
C. Fenoglio,
S. Wergeland,
A. Laroni,
Viviana Annibali,
S. Romano,
A. Martínez,
A. Carrá,
M. Salvetti,
A. Uccelli,
Ø. Torkildsen,
K. Myhr,
D. Galimberti,
K. Rejdak,
J. Lycke,
J. Frederiksen,
J. Drulovic,
C. Confavreux,
D. Brassat,
C. Enzinger,
S. Fuchs,
I. Boscá,
J. Pelletier,
C. Picard,
E. Colombo,
D. Franciotta,
T. Derfuss,
R. Lindberg,
Ö. Yaldizli,
L. Vécsei,
B. Kieseier,
H. Hartung,
P. Villoslada,
A. Siva,
A. Saiz,
H. Tumani,
E. Havrdová,
L. Villar,
M. Leone,
N. Barizzone,
F. Deisenhammer,
C. Teunissen,
X. Montalban,
M. Tintoré,
T. Olsson,
M. Trojano,
S. Lehmann,
G. Castelnovo,
Lapin Sv,
R. Hintzen,
L. Kappos,
R. Furlan,
V. Martinelli,
G. Comi,
S. Ramagopalan,
G. Giovannoni
|
8 |
2015 |
8
🐜
|
|
🐜
|
Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.
13 auth.
E. Beltrán,
B. Obermeier,
M. Moser,
F. Coret,
M. Simó-Castelló,
I. Boscá,
F. Pérez-Miralles,
L. Villar,
M. Senel,
H. Tumani,
...
R. Hohlfeld,
B. Casanova,
K. Dornmair
|
6 |
2014 |
6
🐜
|
|
🐜
|
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
10 auth.
M. Magraner,
I. Boscá,
M. Simó-Castelló,
G. García-Martí,
Á. Alberich-Bayarri,
F. Coret,
...
J. Álvarez-cermeño,
L. Martí-Bonmatí,
L. Villar,
B. Casanova
|
6 |
2011 |
6
🐜
|
|
🐜
|
Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)
9 auth.
Ó. Fernández,
V. Fernández,
T. Arbizu,
G. Izquierdo,
I. Boscá,
R. Arroyo,
...
J. G. García Merino,
E. Ramon,
The Novo Group
|
5 |
2010 |
5
🐜
|
|
🐜
|
Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required
13 auth.
Ana M. Pascual,
N. Téllez,
I. Boscá,
J. Mallada,
A. Belenguer,
Inmaculada Abellán,
Á. Sempere,
P. Fernández,
M. Magraner,
F. Coret,
...
M. Sanz,
X. Montalban,
B. Casanova
|
5 |
2009 |
5
🐜
|
|
🐜
|
Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study
8 auth.
C. Forn,
M. Rocca,
P. Valsasina,
I. Boscá,
B. Casanova,
A. Sanjuán,
...
C. Ávila,
M. Filippi
|
5 |
2012 |
5
🐜
|
|
🐜
|
Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
8 auth.
C. Alcalá,
F. Gascón,
F. Pérez-Miralles,
S. Gil-Perotín,
A. Navarre,
I. Boscá,
...
F. Coret,
B. Casanova
|
5 |
2018 |
5
🐜
|
|
🐜
|
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
17 auth.
B. Casanova,
I. Jarque,
F. Gascón,
J. Hernández-Boluda,
F. Pérez-Miralles,
J. de la Rubia,
C. Alcalá,
J. Sanz,
J. Mallada,
A. Cervelló,
...
A. Navarre,
María Carcelén-Gadea,
I. Boscá,
S. Gil-Perotín,
C. Solano,
M. Sanz,
F. Coret
|
5 |
2017 |
5
🐜
|
|
🐜
|
Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study
9 auth.
M. Magraner,
F. Coret,
A. Navarre,
I. Boscá,
M. Simó,
M. Escutia,
...
Ana Bernad,
L. Navarro,
B. Casanova
|
5 |
2011 |
5
🐜
|
